Global Pharmaceutical Intermediates Market Insights, Forecast to 2026
Pharmaceutical intermediates are chemical material or chemical products, which could be applied in production of active pharmaceutical ingredients. Their production needs not production certification and they can be produced in ordinary chemical factory. There are many kinds of pharmaceutical intermediates, such as cephalosporin intermediates, vitamin intermediates, quinolones intermediates, steroid intermediates, etc.
This industry is affected by the economy and policy, so it’s important to put an eye to economic indexes and leaders’ prefer. With the global economic recovery, more and more people pay attention to rising environment standards, especially in underdevelopment regions that have a large population and fast economic growth, the need will increase.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Pharmaceutical Intermediates 3900 market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Pharmaceutical Intermediates 3900 industry.
Based on our recent survey, we have several different scenarios about the Pharmaceutical Intermediates 3900 YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ 160290 million in 2019. The market size of Pharmaceutical Intermediates 3900 will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Pharmaceutical Intermediates market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Pharmaceutical Intermediates market in terms of both revenue and volume.
Players, stakeholders, and other participants in the global Pharmaceutical Intermediates market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on sales (volume), revenue and forecast by each application segment in terms of sales and revenue and forecast by each type segment in terms of revenue for the period 2015-2026.
Sales and Pricing Analyses
Readers are provided with deeper sales analysis and pricing analysis for the global Pharmaceutical Intermediates market. As part of sales analysis, the report offers accurate statistics and figures for sales and revenue by region, by each type segment for the period 2015-2026.
In the pricing analysis section of the report, readers are provided with validated statistics and figures for the price by players and price by region for the period 2015-2020 and price by each type segment for the period 2015-2020.
Regional and Country-level Analysis
The report offers an exhaustive geographical analysis of the global Pharmaceutical Intermediates market, covering important regions, viz, North America, Europe, China and Japan. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, UAE, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of sales for the period 2015-2026.
Competition Analysis
In the competitive analysis section of the report, leading as well as prominent players of the global Pharmaceutical Intermediates market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on sales by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Pharmaceutical Intermediates market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Pharmaceutical Intermediates market.
The following manufacturers are covered in this report:
This industry is affected by the economy and policy, so it’s important to put an eye to economic indexes and leaders’ prefer. With the global economic recovery, more and more people pay attention to rising environment standards, especially in underdevelopment regions that have a large population and fast economic growth, the need will increase.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Pharmaceutical Intermediates 3900 market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Pharmaceutical Intermediates 3900 industry.
Based on our recent survey, we have several different scenarios about the Pharmaceutical Intermediates 3900 YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ 160290 million in 2019. The market size of Pharmaceutical Intermediates 3900 will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Pharmaceutical Intermediates market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Pharmaceutical Intermediates market in terms of both revenue and volume.
Players, stakeholders, and other participants in the global Pharmaceutical Intermediates market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on sales (volume), revenue and forecast by each application segment in terms of sales and revenue and forecast by each type segment in terms of revenue for the period 2015-2026.
Sales and Pricing Analyses
Readers are provided with deeper sales analysis and pricing analysis for the global Pharmaceutical Intermediates market. As part of sales analysis, the report offers accurate statistics and figures for sales and revenue by region, by each type segment for the period 2015-2026.
In the pricing analysis section of the report, readers are provided with validated statistics and figures for the price by players and price by region for the period 2015-2020 and price by each type segment for the period 2015-2020.
Regional and Country-level Analysis
The report offers an exhaustive geographical analysis of the global Pharmaceutical Intermediates market, covering important regions, viz, North America, Europe, China and Japan. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, UAE, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of sales for the period 2015-2026.
Competition Analysis
In the competitive analysis section of the report, leading as well as prominent players of the global Pharmaceutical Intermediates market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on sales by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Pharmaceutical Intermediates market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Pharmaceutical Intermediates market.
The following manufacturers are covered in this report:
- Lonza
- Catalent
- Patheon
- Jubilant
- Granules
- Ganesh
- Chemcon
- BASF
- Porton
- Lianhetech
- ABA Chem
- Tianma
- Jiujiujiu
- Alpha
- Jiuzhou
- Yongtai
- GMP
- Non-GMP
- Antibiotics
- Antipyretic Analgesics
- Vitamins
- Others
1 STUDY COVERAGE
1.1 Pharmaceutical Intermediates Product Introduction
1.2 Market Segments
1.3 Key Pharmaceutical Intermediates Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Pharmaceutical Intermediates Market Size Growth Rate by Type
1.4.2 GMP
1.4.3 Non-GMP
1.5 Market by Application
1.5.1 Global Pharmaceutical Intermediates Market Size Growth Rate by Application
1.5.2 Antibiotics
1.5.3 Antipyretic Analgesics
1.5.4 Vitamins
1.5.5 Others
1.6 Coronavirus Disease 2019 (Covid-19): Pharmaceutical Intermediates Industry Impact
1.6.1 How the Covid-19 is Affecting the Pharmaceutical Intermediates Industry
1.6.1.1 Pharmaceutical Intermediates Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Pharmaceutical Intermediates Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Pharmaceutical Intermediates Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global Pharmaceutical Intermediates Market Size Estimates and Forecasts
2.1.1 Global Pharmaceutical Intermediates Revenue 2015-2026
2.1.2 Global Pharmaceutical Intermediates Sales 2015-2026
2.2 Pharmaceutical Intermediates Market Size by Region: 2020 Versus 2026
2.2.1 Global Pharmaceutical Intermediates Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Pharmaceutical Intermediates Retrospective Market Scenario in Revenue by Region: 2015-2020
3 GLOBAL PHARMACEUTICAL INTERMEDIATES COMPETITOR LANDSCAPE BY PLAYERS
3.1 Pharmaceutical Intermediates Sales by Manufacturers
3.1.1 Pharmaceutical Intermediates Sales by Manufacturers (2015-2020)
3.1.2 Pharmaceutical Intermediates Sales Market Share by Manufacturers (2015-2020)
3.2 Pharmaceutical Intermediates Revenue by Manufacturers
3.2.1 Pharmaceutical Intermediates Revenue by Manufacturers (2015-2020)
3.2.2 Pharmaceutical Intermediates Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Pharmaceutical Intermediates Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Pharmaceutical Intermediates Revenue in 2019
3.2.5 Global Pharmaceutical Intermediates Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Pharmaceutical Intermediates Price by Manufacturers
3.4 Pharmaceutical Intermediates Manufacturing Base Distribution, Product Types
3.4.1 Pharmaceutical Intermediates Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Pharmaceutical Intermediates Product Type
3.4.3 Date of International Manufacturers Enter into Pharmaceutical Intermediates Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Pharmaceutical Intermediates Market Size by Type (2015-2020)
4.1.1 Global Pharmaceutical Intermediates Sales by Type (2015-2020)
4.1.2 Global Pharmaceutical Intermediates Revenue by Type (2015-2020)
4.1.3 Pharmaceutical Intermediates Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Pharmaceutical Intermediates Market Size Forecast by Type (2021-2026)
4.2.1 Global Pharmaceutical Intermediates Sales Forecast by Type (2021-2026)
4.2.2 Global Pharmaceutical Intermediates Revenue Forecast by Type (2021-2026)
4.2.3 Pharmaceutical Intermediates Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Pharmaceutical Intermediates Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Pharmaceutical Intermediates Market Size by Application (2015-2020)
5.1.1 Global Pharmaceutical Intermediates Sales by Application (2015-2020)
5.1.2 Global Pharmaceutical Intermediates Revenue by Application (2015-2020)
5.1.3 Pharmaceutical Intermediates Price by Application (2015-2020)
5.2 Pharmaceutical Intermediates Market Size Forecast by Application (2021-2026)
5.2.1 Global Pharmaceutical Intermediates Sales Forecast by Application (2021-2026)
5.2.2 Global Pharmaceutical Intermediates Revenue Forecast by Application (2021-2026)
5.2.3 Global Pharmaceutical Intermediates Price Forecast by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Pharmaceutical Intermediates by Country
6.1.1 North America Pharmaceutical Intermediates Sales by Country
6.1.2 North America Pharmaceutical Intermediates Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Pharmaceutical Intermediates Market Facts & Figures by Type
6.3 North America Pharmaceutical Intermediates Market Facts & Figures by Application
7 EUROPE
7.1 Europe Pharmaceutical Intermediates by Country
7.1.1 Europe Pharmaceutical Intermediates Sales by Country
7.1.2 Europe Pharmaceutical Intermediates Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Pharmaceutical Intermediates Market Facts & Figures by Type
7.3 Europe Pharmaceutical Intermediates Market Facts & Figures by Application
8 ASIA PACIFIC
8.1 Asia Pacific Pharmaceutical Intermediates by Region
8.1.1 Asia Pacific Pharmaceutical Intermediates Sales by Region
8.1.2 Asia Pacific Pharmaceutical Intermediates Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Pharmaceutical Intermediates Market Facts & Figures by Type
8.3 Asia Pacific Pharmaceutical Intermediates Market Facts & Figures by Application
9 LATIN AMERICA
9.1 Latin America Pharmaceutical Intermediates by Country
9.1.1 Latin America Pharmaceutical Intermediates Sales by Country
9.1.2 Latin America Pharmaceutical Intermediates Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Pharmaceutical Intermediates Market Facts & Figures by Type
9.3 Central & South America Pharmaceutical Intermediates Market Facts & Figures by Application
10 MIDDLE EAST AND AFRICA
10.1 Middle East and Africa Pharmaceutical Intermediates by Country
10.1.1 Middle East and Africa Pharmaceutical Intermediates Sales by Country
10.1.2 Middle East and Africa Pharmaceutical Intermediates Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 UAE
10.2 Middle East and Africa Pharmaceutical Intermediates Market Facts & Figures by Type
10.3 Middle East and Africa Pharmaceutical Intermediates Market Facts & Figures by Application
11 COMPANY PROFILES
11.1 Lonza
11.1.1 Lonza Corporation Information
11.1.2 Lonza Description, Business Overview and Total Revenue
11.1.3 Lonza Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Lonza Pharmaceutical Intermediates Products Offered
11.1.5 Lonza Recent Development
11.2 Catalent
11.2.1 Catalent Corporation Information
11.2.2 Catalent Description, Business Overview and Total Revenue
11.2.3 Catalent Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Catalent Pharmaceutical Intermediates Products Offered
11.2.5 Catalent Recent Development
11.3 Patheon
11.3.1 Patheon Corporation Information
11.3.2 Patheon Description, Business Overview and Total Revenue
11.3.3 Patheon Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Patheon Pharmaceutical Intermediates Products Offered
11.3.5 Patheon Recent Development
11.4 Jubilant
11.4.1 Jubilant Corporation Information
11.4.2 Jubilant Description, Business Overview and Total Revenue
11.4.3 Jubilant Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Jubilant Pharmaceutical Intermediates Products Offered
11.4.5 Jubilant Recent Development
11.5 Granules
11.5.1 Granules Corporation Information
11.5.2 Granules Description, Business Overview and Total Revenue
11.5.3 Granules Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Granules Pharmaceutical Intermediates Products Offered
11.5.5 Granules Recent Development
11.6 Ganesh
11.6.1 Ganesh Corporation Information
11.6.2 Ganesh Description, Business Overview and Total Revenue
11.6.3 Ganesh Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Ganesh Pharmaceutical Intermediates Products Offered
11.6.5 Ganesh Recent Development
11.7 Chemcon
11.7.1 Chemcon Corporation Information
11.7.2 Chemcon Description, Business Overview and Total Revenue
11.7.3 Chemcon Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Chemcon Pharmaceutical Intermediates Products Offered
11.7.5 Chemcon Recent Development
11.8 BASF
11.8.1 BASF Corporation Information
11.8.2 BASF Description, Business Overview and Total Revenue
11.8.3 BASF Sales, Revenue and Gross Margin (2015-2020)
11.8.4 BASF Pharmaceutical Intermediates Products Offered
11.8.5 BASF Recent Development
11.9 Porton
11.9.1 Porton Corporation Information
11.9.2 Porton Description, Business Overview and Total Revenue
11.9.3 Porton Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Porton Pharmaceutical Intermediates Products Offered
11.9.5 Porton Recent Development
11.10 Lianhetech
11.10.1 Lianhetech Corporation Information
11.10.2 Lianhetech Description, Business Overview and Total Revenue
11.10.3 Lianhetech Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Lianhetech Pharmaceutical Intermediates Products Offered
11.10.5 Lianhetech Recent Development
11.1 Lonza
11.1.1 Lonza Corporation Information
11.1.2 Lonza Description, Business Overview and Total Revenue
11.1.3 Lonza Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Lonza Pharmaceutical Intermediates Products Offered
11.1.5 Lonza Recent Development
11.12 Tianma
11.12.1 Tianma Corporation Information
11.12.2 Tianma Description, Business Overview and Total Revenue
11.12.3 Tianma Sales, Revenue and Gross Margin (2015-2020)
11.12.4 Tianma Products Offered
11.12.5 Tianma Recent Development
11.13 Jiujiujiu
11.13.1 Jiujiujiu Corporation Information
11.13.2 Jiujiujiu Description, Business Overview and Total Revenue
11.13.3 Jiujiujiu Sales, Revenue and Gross Margin (2015-2020)
11.13.4 Jiujiujiu Products Offered
11.13.5 Jiujiujiu Recent Development
11.14 Alpha
11.14.1 Alpha Corporation Information
11.14.2 Alpha Description, Business Overview and Total Revenue
11.14.3 Alpha Sales, Revenue and Gross Margin (2015-2020)
11.14.4 Alpha Products Offered
11.14.5 Alpha Recent Development
11.15 Jiuzhou
11.15.1 Jiuzhou Corporation Information
11.15.2 Jiuzhou Description, Business Overview and Total Revenue
11.15.3 Jiuzhou Sales, Revenue and Gross Margin (2015-2020)
11.15.4 Jiuzhou Products Offered
11.15.5 Jiuzhou Recent Development
11.16 Yongtai
11.16.1 Yongtai Corporation Information
11.16.2 Yongtai Description, Business Overview and Total Revenue
11.16.3 Yongtai Sales, Revenue and Gross Margin (2015-2020)
11.16.4 Yongtai Products Offered
11.16.5 Yongtai Recent Development
12 FUTURE FORECAST BY REGIONS (COUNTRIES) (2021-2026)
12.1 Pharmaceutical Intermediates Market Estimates and Projections by Region
12.1.1 Global Pharmaceutical Intermediates Sales Forecast by Regions 2021-2026
12.1.2 Global Pharmaceutical Intermediates Revenue Forecast by Regions 2021-2026
12.2 North America Pharmaceutical Intermediates Market Size Forecast (2021-2026)
12.2.1 North America: Pharmaceutical Intermediates Sales Forecast (2021-2026)
12.2.2 North America: Pharmaceutical Intermediates Revenue Forecast (2021-2026)
12.2.3 North America: Pharmaceutical Intermediates Market Size Forecast by Country (2021-2026)
12.3 Europe Pharmaceutical Intermediates Market Size Forecast (2021-2026)
12.3.1 Europe: Pharmaceutical Intermediates Sales Forecast (2021-2026)
12.3.2 Europe: Pharmaceutical Intermediates Revenue Forecast (2021-2026)
12.3.3 Europe: Pharmaceutical Intermediates Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Pharmaceutical Intermediates Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Pharmaceutical Intermediates Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Pharmaceutical Intermediates Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Pharmaceutical Intermediates Market Size Forecast by Region (2021-2026)
12.5 Latin America Pharmaceutical Intermediates Market Size Forecast (2021-2026)
12.5.1 Latin America: Pharmaceutical Intermediates Sales Forecast (2021-2026)
12.5.2 Latin America: Pharmaceutical Intermediates Revenue Forecast (2021-2026)
12.5.3 Latin America: Pharmaceutical Intermediates Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Pharmaceutical Intermediates Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Pharmaceutical Intermediates Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Pharmaceutical Intermediates Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Pharmaceutical Intermediates Market Size Forecast by Country (2021-2026)
13 MARKET OPPORTUNITIES, CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Pharmaceutical Intermediates Players (Opinion Leaders)
14 VALUE CHAIN AND SALES CHANNELS ANALYSIS
14.1 Value Chain Analysis
14.2 Pharmaceutical Intermediates Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
1.1 Pharmaceutical Intermediates Product Introduction
1.2 Market Segments
1.3 Key Pharmaceutical Intermediates Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Pharmaceutical Intermediates Market Size Growth Rate by Type
1.4.2 GMP
1.4.3 Non-GMP
1.5 Market by Application
1.5.1 Global Pharmaceutical Intermediates Market Size Growth Rate by Application
1.5.2 Antibiotics
1.5.3 Antipyretic Analgesics
1.5.4 Vitamins
1.5.5 Others
1.6 Coronavirus Disease 2019 (Covid-19): Pharmaceutical Intermediates Industry Impact
1.6.1 How the Covid-19 is Affecting the Pharmaceutical Intermediates Industry
1.6.1.1 Pharmaceutical Intermediates Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Pharmaceutical Intermediates Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Pharmaceutical Intermediates Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global Pharmaceutical Intermediates Market Size Estimates and Forecasts
2.1.1 Global Pharmaceutical Intermediates Revenue 2015-2026
2.1.2 Global Pharmaceutical Intermediates Sales 2015-2026
2.2 Pharmaceutical Intermediates Market Size by Region: 2020 Versus 2026
2.2.1 Global Pharmaceutical Intermediates Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Pharmaceutical Intermediates Retrospective Market Scenario in Revenue by Region: 2015-2020
3 GLOBAL PHARMACEUTICAL INTERMEDIATES COMPETITOR LANDSCAPE BY PLAYERS
3.1 Pharmaceutical Intermediates Sales by Manufacturers
3.1.1 Pharmaceutical Intermediates Sales by Manufacturers (2015-2020)
3.1.2 Pharmaceutical Intermediates Sales Market Share by Manufacturers (2015-2020)
3.2 Pharmaceutical Intermediates Revenue by Manufacturers
3.2.1 Pharmaceutical Intermediates Revenue by Manufacturers (2015-2020)
3.2.2 Pharmaceutical Intermediates Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Pharmaceutical Intermediates Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Pharmaceutical Intermediates Revenue in 2019
3.2.5 Global Pharmaceutical Intermediates Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Pharmaceutical Intermediates Price by Manufacturers
3.4 Pharmaceutical Intermediates Manufacturing Base Distribution, Product Types
3.4.1 Pharmaceutical Intermediates Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Pharmaceutical Intermediates Product Type
3.4.3 Date of International Manufacturers Enter into Pharmaceutical Intermediates Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Pharmaceutical Intermediates Market Size by Type (2015-2020)
4.1.1 Global Pharmaceutical Intermediates Sales by Type (2015-2020)
4.1.2 Global Pharmaceutical Intermediates Revenue by Type (2015-2020)
4.1.3 Pharmaceutical Intermediates Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Pharmaceutical Intermediates Market Size Forecast by Type (2021-2026)
4.2.1 Global Pharmaceutical Intermediates Sales Forecast by Type (2021-2026)
4.2.2 Global Pharmaceutical Intermediates Revenue Forecast by Type (2021-2026)
4.2.3 Pharmaceutical Intermediates Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Pharmaceutical Intermediates Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Pharmaceutical Intermediates Market Size by Application (2015-2020)
5.1.1 Global Pharmaceutical Intermediates Sales by Application (2015-2020)
5.1.2 Global Pharmaceutical Intermediates Revenue by Application (2015-2020)
5.1.3 Pharmaceutical Intermediates Price by Application (2015-2020)
5.2 Pharmaceutical Intermediates Market Size Forecast by Application (2021-2026)
5.2.1 Global Pharmaceutical Intermediates Sales Forecast by Application (2021-2026)
5.2.2 Global Pharmaceutical Intermediates Revenue Forecast by Application (2021-2026)
5.2.3 Global Pharmaceutical Intermediates Price Forecast by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Pharmaceutical Intermediates by Country
6.1.1 North America Pharmaceutical Intermediates Sales by Country
6.1.2 North America Pharmaceutical Intermediates Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Pharmaceutical Intermediates Market Facts & Figures by Type
6.3 North America Pharmaceutical Intermediates Market Facts & Figures by Application
7 EUROPE
7.1 Europe Pharmaceutical Intermediates by Country
7.1.1 Europe Pharmaceutical Intermediates Sales by Country
7.1.2 Europe Pharmaceutical Intermediates Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Pharmaceutical Intermediates Market Facts & Figures by Type
7.3 Europe Pharmaceutical Intermediates Market Facts & Figures by Application
8 ASIA PACIFIC
8.1 Asia Pacific Pharmaceutical Intermediates by Region
8.1.1 Asia Pacific Pharmaceutical Intermediates Sales by Region
8.1.2 Asia Pacific Pharmaceutical Intermediates Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Pharmaceutical Intermediates Market Facts & Figures by Type
8.3 Asia Pacific Pharmaceutical Intermediates Market Facts & Figures by Application
9 LATIN AMERICA
9.1 Latin America Pharmaceutical Intermediates by Country
9.1.1 Latin America Pharmaceutical Intermediates Sales by Country
9.1.2 Latin America Pharmaceutical Intermediates Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Pharmaceutical Intermediates Market Facts & Figures by Type
9.3 Central & South America Pharmaceutical Intermediates Market Facts & Figures by Application
10 MIDDLE EAST AND AFRICA
10.1 Middle East and Africa Pharmaceutical Intermediates by Country
10.1.1 Middle East and Africa Pharmaceutical Intermediates Sales by Country
10.1.2 Middle East and Africa Pharmaceutical Intermediates Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 UAE
10.2 Middle East and Africa Pharmaceutical Intermediates Market Facts & Figures by Type
10.3 Middle East and Africa Pharmaceutical Intermediates Market Facts & Figures by Application
11 COMPANY PROFILES
11.1 Lonza
11.1.1 Lonza Corporation Information
11.1.2 Lonza Description, Business Overview and Total Revenue
11.1.3 Lonza Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Lonza Pharmaceutical Intermediates Products Offered
11.1.5 Lonza Recent Development
11.2 Catalent
11.2.1 Catalent Corporation Information
11.2.2 Catalent Description, Business Overview and Total Revenue
11.2.3 Catalent Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Catalent Pharmaceutical Intermediates Products Offered
11.2.5 Catalent Recent Development
11.3 Patheon
11.3.1 Patheon Corporation Information
11.3.2 Patheon Description, Business Overview and Total Revenue
11.3.3 Patheon Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Patheon Pharmaceutical Intermediates Products Offered
11.3.5 Patheon Recent Development
11.4 Jubilant
11.4.1 Jubilant Corporation Information
11.4.2 Jubilant Description, Business Overview and Total Revenue
11.4.3 Jubilant Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Jubilant Pharmaceutical Intermediates Products Offered
11.4.5 Jubilant Recent Development
11.5 Granules
11.5.1 Granules Corporation Information
11.5.2 Granules Description, Business Overview and Total Revenue
11.5.3 Granules Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Granules Pharmaceutical Intermediates Products Offered
11.5.5 Granules Recent Development
11.6 Ganesh
11.6.1 Ganesh Corporation Information
11.6.2 Ganesh Description, Business Overview and Total Revenue
11.6.3 Ganesh Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Ganesh Pharmaceutical Intermediates Products Offered
11.6.5 Ganesh Recent Development
11.7 Chemcon
11.7.1 Chemcon Corporation Information
11.7.2 Chemcon Description, Business Overview and Total Revenue
11.7.3 Chemcon Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Chemcon Pharmaceutical Intermediates Products Offered
11.7.5 Chemcon Recent Development
11.8 BASF
11.8.1 BASF Corporation Information
11.8.2 BASF Description, Business Overview and Total Revenue
11.8.3 BASF Sales, Revenue and Gross Margin (2015-2020)
11.8.4 BASF Pharmaceutical Intermediates Products Offered
11.8.5 BASF Recent Development
11.9 Porton
11.9.1 Porton Corporation Information
11.9.2 Porton Description, Business Overview and Total Revenue
11.9.3 Porton Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Porton Pharmaceutical Intermediates Products Offered
11.9.5 Porton Recent Development
11.10 Lianhetech
11.10.1 Lianhetech Corporation Information
11.10.2 Lianhetech Description, Business Overview and Total Revenue
11.10.3 Lianhetech Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Lianhetech Pharmaceutical Intermediates Products Offered
11.10.5 Lianhetech Recent Development
11.1 Lonza
11.1.1 Lonza Corporation Information
11.1.2 Lonza Description, Business Overview and Total Revenue
11.1.3 Lonza Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Lonza Pharmaceutical Intermediates Products Offered
11.1.5 Lonza Recent Development
11.12 Tianma
11.12.1 Tianma Corporation Information
11.12.2 Tianma Description, Business Overview and Total Revenue
11.12.3 Tianma Sales, Revenue and Gross Margin (2015-2020)
11.12.4 Tianma Products Offered
11.12.5 Tianma Recent Development
11.13 Jiujiujiu
11.13.1 Jiujiujiu Corporation Information
11.13.2 Jiujiujiu Description, Business Overview and Total Revenue
11.13.3 Jiujiujiu Sales, Revenue and Gross Margin (2015-2020)
11.13.4 Jiujiujiu Products Offered
11.13.5 Jiujiujiu Recent Development
11.14 Alpha
11.14.1 Alpha Corporation Information
11.14.2 Alpha Description, Business Overview and Total Revenue
11.14.3 Alpha Sales, Revenue and Gross Margin (2015-2020)
11.14.4 Alpha Products Offered
11.14.5 Alpha Recent Development
11.15 Jiuzhou
11.15.1 Jiuzhou Corporation Information
11.15.2 Jiuzhou Description, Business Overview and Total Revenue
11.15.3 Jiuzhou Sales, Revenue and Gross Margin (2015-2020)
11.15.4 Jiuzhou Products Offered
11.15.5 Jiuzhou Recent Development
11.16 Yongtai
11.16.1 Yongtai Corporation Information
11.16.2 Yongtai Description, Business Overview and Total Revenue
11.16.3 Yongtai Sales, Revenue and Gross Margin (2015-2020)
11.16.4 Yongtai Products Offered
11.16.5 Yongtai Recent Development
12 FUTURE FORECAST BY REGIONS (COUNTRIES) (2021-2026)
12.1 Pharmaceutical Intermediates Market Estimates and Projections by Region
12.1.1 Global Pharmaceutical Intermediates Sales Forecast by Regions 2021-2026
12.1.2 Global Pharmaceutical Intermediates Revenue Forecast by Regions 2021-2026
12.2 North America Pharmaceutical Intermediates Market Size Forecast (2021-2026)
12.2.1 North America: Pharmaceutical Intermediates Sales Forecast (2021-2026)
12.2.2 North America: Pharmaceutical Intermediates Revenue Forecast (2021-2026)
12.2.3 North America: Pharmaceutical Intermediates Market Size Forecast by Country (2021-2026)
12.3 Europe Pharmaceutical Intermediates Market Size Forecast (2021-2026)
12.3.1 Europe: Pharmaceutical Intermediates Sales Forecast (2021-2026)
12.3.2 Europe: Pharmaceutical Intermediates Revenue Forecast (2021-2026)
12.3.3 Europe: Pharmaceutical Intermediates Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Pharmaceutical Intermediates Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Pharmaceutical Intermediates Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Pharmaceutical Intermediates Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Pharmaceutical Intermediates Market Size Forecast by Region (2021-2026)
12.5 Latin America Pharmaceutical Intermediates Market Size Forecast (2021-2026)
12.5.1 Latin America: Pharmaceutical Intermediates Sales Forecast (2021-2026)
12.5.2 Latin America: Pharmaceutical Intermediates Revenue Forecast (2021-2026)
12.5.3 Latin America: Pharmaceutical Intermediates Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Pharmaceutical Intermediates Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Pharmaceutical Intermediates Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Pharmaceutical Intermediates Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Pharmaceutical Intermediates Market Size Forecast by Country (2021-2026)
13 MARKET OPPORTUNITIES, CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Pharmaceutical Intermediates Players (Opinion Leaders)
14 VALUE CHAIN AND SALES CHANNELS ANALYSIS
14.1 Value Chain Analysis
14.2 Pharmaceutical Intermediates Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
LIST OF TABLES
Table 1. Pharmaceutical Intermediates Market Segments
Table 2. Ranking of Global Top Pharmaceutical Intermediates Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Pharmaceutical Intermediates Market Size Growth Rate by Type 2020-2026 (K MT) & (US$ Million)
Table 4. Major Manufacturers of GMP
Table 5. Major Manufacturers of Non-GMP
Table 6. COVID-19 Impact Global Market: (Four Pharmaceutical Intermediates Market Size Forecast Scenarios)
Table 7. Opportunities and Trends for Pharmaceutical Intermediates Players in the COVID-19 Landscape
Table 8. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 9. Key Regions/Countries Measures against Covid-19 Impact
Table 10. Proposal for Pharmaceutical Intermediates Players to Combat Covid-19 Impact
Table 11. Global Pharmaceutical Intermediates Market Size Growth Rate by Application 2020-2026 (K MT)
Table 12. Global Pharmaceutical Intermediates Market Size by Region (K MT) & (US$ Million): 2020 VS 2026
Table 13. Global Pharmaceutical Intermediates Sales by Regions 2015-2020 (K MT)
Table 14. Global Pharmaceutical Intermediates Sales Market Share by Regions (2015-2020)
Table 15. Global Pharmaceutical Intermediates Revenue by Regions 2015-2020 (US$ Million)
Table 16. Global Pharmaceutical Intermediates Sales by Manufacturers (2015-2020) (K MT)
Table 17. Global Pharmaceutical Intermediates Sales Share by Manufacturers (2015-2020)
Table 18. Global Pharmaceutical Intermediates Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 19. Global Pharmaceutical Intermediates by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pharmaceutical Intermediates as of 2019)
Table 20. Pharmaceutical Intermediates Revenue by Manufacturers (2015-2020) (US$ Million)
Table 21. Pharmaceutical Intermediates Revenue Share by Manufacturers (2015-2020)
Table 22. Key Manufacturers Pharmaceutical Intermediates Price (2015-2020) (USD/MT)
Table 23. Pharmaceutical Intermediates Manufacturers Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Pharmaceutical Intermediates Product Type
Table 25. Date of International Manufacturers Enter into Pharmaceutical Intermediates Market
Table 26. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 27. Global Pharmaceutical Intermediates Sales by Type (2015-2020) (K MT)
Table 28. Global Pharmaceutical Intermediates Sales Share by Type (2015-2020)
Table 29. Global Pharmaceutical Intermediates Revenue by Type (2015-2020) (US$ Million)
Table 30. Global Pharmaceutical Intermediates Revenue Share by Type (2015-2020)
Table 31. Pharmaceutical Intermediates Average Selling Price (ASP) by Type 2015-2020 (USD/MT)
Table 32. Global Pharmaceutical Intermediates Sales by Application (2015-2020) (K MT)
Table 33. Global Pharmaceutical Intermediates Sales Share by Application (2015-2020)
Table 34. North America Pharmaceutical Intermediates Sales by Country (2015-2020) (K MT)
Table 35. North America Pharmaceutical Intermediates Sales Market Share by Country (2015-2020)
Table 36. North America Pharmaceutical Intermediates Revenue by Country (2015-2020) (US$ Million)
Table 37. North America Pharmaceutical Intermediates Revenue Market Share by Country (2015-2020)
Table 38. North America Pharmaceutical Intermediates Sales by Type (2015-2020) (K MT)
Table 39. North America Pharmaceutical Intermediates Sales Market Share by Type (2015-2020)
Table 40. North America Pharmaceutical Intermediates Sales by Application (2015-2020) (K MT)
Table 41. North America Pharmaceutical Intermediates Sales Market Share by Application (2015-2020)
Table 42. Europe Pharmaceutical Intermediates Sales by Country (2015-2020) (K MT)
Table 43. Europe Pharmaceutical Intermediates Sales Market Share by Country (2015-2020)
Table 44. Europe Pharmaceutical Intermediates Revenue by Country (2015-2020) (US$ Million)
Table 45. Europe Pharmaceutical Intermediates Revenue Market Share by Country (2015-2020)
Table 46. Europe Pharmaceutical Intermediates Sales by Type (2015-2020) (K MT)
Table 47. Europe Pharmaceutical Intermediates Sales Market Share by Type (2015-2020)
Table 48. Europe Pharmaceutical Intermediates Sales by Application (2015-2020) (K MT)
Table 49. Europe Pharmaceutical Intermediates Sales Market Share by Application (2015-2020)
Table 50. Asia Pacific Pharmaceutical Intermediates Sales by Region (2015-2020) (K MT)
Table 51. Asia Pacific Pharmaceutical Intermediates Sales Market Share by Region (2015-2020)
Table 52. Asia Pacific Pharmaceutical Intermediates Revenue by Region (2015-2020) (US$ Million)
Table 53. Asia Pacific Pharmaceutical Intermediates Revenue Market Share by Region (2015-2020)
Table 54. Asia Pacific Pharmaceutical Intermediates Sales by Type (2015-2020) (K MT)
Table 55. Asia Pacific Pharmaceutical Intermediates Sales Market Share by Type (2015-2020)
Table 56. Asia Pacific Pharmaceutical Intermediates Sales by Application (2015-2020) (K MT)
Table 57. Asia Pacific Pharmaceutical Intermediates Sales Market Share by Application (2015-2020)
Table 58. Latin America Pharmaceutical Intermediates Sales by Country (2015-2020) (K MT)
Table 59. Latin America Pharmaceutical Intermediates Sales Market Share by Country (2015-2020)
Table 60. Latin Americaa Pharmaceutical Intermediates Revenue by Country (2015-2020) (US$ Million)
Table 61. Latin America Pharmaceutical Intermediates Revenue Market Share by Country (2015-2020)
Table 62. Latin America Pharmaceutical Intermediates Sales by Type (2015-2020) (K MT)
Table 63. Latin America Pharmaceutical Intermediates Sales Market Share by Type (2015-2020)
Table 64. Latin America Pharmaceutical Intermediates Sales by Application (2015-2020) (K MT)
Table 65. Latin America Pharmaceutical Intermediates Sales Market Share by Application (2015-2020)
Table 66. Middle East and Africa Pharmaceutical Intermediates Sales by Country (2015-2020) (K MT)
Table 67. Middle East and Africa Pharmaceutical Intermediates Sales Market Share by Country (2015-2020)
Table 68. Middle East and Africa Pharmaceutical Intermediates Revenue by Country (2015-2020) (US$ Million)
Table 69. Middle East and Africa Pharmaceutical Intermediates Revenue Market Share by Country (2015-2020)
Table 70. Middle East and Africa Pharmaceutical Intermediates Sales by Type (2015-2020) (K MT)
Table 71. Middle East and Africa Pharmaceutical Intermediates Sales Market Share by Type (2015-2020)
Table 72. Middle East and Africa Pharmaceutical Intermediates Sales by Application (2015-2020) (K MT)
Table 73. Middle East and Africa Pharmaceutical Intermediates Sales Market Share by Application (2015-2020)
Table 74. Lonza Corporation Information
Table 75. Lonza Description and Major Businesses
Table 76. Lonza Pharmaceutical Intermediates Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 77. Lonza Product
Table 78. Lonza Recent Development
Table 79. Catalent Corporation Information
Table 80. Catalent Description and Major Businesses
Table 81. Catalent Pharmaceutical Intermediates Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 82. Catalent Product
Table 83. Catalent Recent Development
Table 84. Patheon Corporation Information
Table 85. Patheon Description and Major Businesses
Table 86. Patheon Pharmaceutical Intermediates Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 87. Patheon Product
Table 88. Patheon Recent Development
Table 89. Jubilant Corporation Information
Table 90. Jubilant Description and Major Businesses
Table 91. Jubilant Pharmaceutical Intermediates Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 92. Jubilant Product
Table 93. Jubilant Recent Development
Table 94. Granules Corporation Information
Table 95. Granules Description and Major Businesses
Table 96. Granules Pharmaceutical Intermediates Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 97. Granules Product
Table 98. Granules Recent Development
Table 99. Ganesh Corporation Information
Table 100. Ganesh Description and Major Businesses
Table 101. Ganesh Pharmaceutical Intermediates Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 102. Ganesh Product
Table 103. Ganesh Recent Development
Table 104. Chemcon Corporation Information
Table 105. Chemcon Description and Major Businesses
Table 106. Chemcon Pharmaceutical Intermediates Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 107. Chemcon Product
Table 108. Chemcon Recent Development
Table 109. BASF Corporation Information
Table 110. BASF Description and Major Businesses
Table 111. BASF Pharmaceutical Intermediates Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 112. BASF Product
Table 113. BASF Recent Development
Table 114. Porton Corporation Information
Table 115. Porton Description and Major Businesses
Table 116. Porton Pharmaceutical Intermediates Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 117. Porton Product
Table 118. Porton Recent Development
Table 119. Lianhetech Corporation Information
Table 120. Lianhetech Description and Major Businesses
Table 121. Lianhetech Pharmaceutical Intermediates Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 122. Lianhetech Product
Table 123. Lianhetech Recent Development
Table 124. ABA Chem Corporation Information
Table 125. ABA Chem Description and Major Businesses
Table 126. ABA Chem Pharmaceutical Intermediates Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 127. ABA Chem Product
Table 128. ABA Chem Recent Development
Table 129. Tianma Corporation Information
Table 130. Tianma Description and Major Businesses
Table 131. Tianma Pharmaceutical Intermediates Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 132. Tianma Product
Table 133. Tianma Recent Development
Table 134. Jiujiujiu Corporation Information
Table 135. Jiujiujiu Description and Major Businesses
Table 136. Jiujiujiu Pharmaceutical Intermediates Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 137. Jiujiujiu Product
Table 138. Jiujiujiu Recent Development
Table 139. Alpha Corporation Information
Table 140. Alpha Description and Major Businesses
Table 141. Alpha Pharmaceutical Intermediates Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 142. Alpha Product
Table 143. Alpha Recent Development
Table 144. Jiuzhou Corporation Information
Table 145. Jiuzhou Description and Major Businesses
Table 146. Jiuzhou Pharmaceutical Intermediates Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 147. Jiuzhou Product
Table 148. Jiuzhou Recent Development
Table 149. Yongtai Corporation Information
Table 150. Yongtai Description and Major Businesses
Table 151. Yongtai Pharmaceutical Intermediates Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 152. Yongtai Product
Table 153. Yongtai Recent Development
Table 154. Global Pharmaceutical Intermediates Sales Forecast by Regions (2021-2026) (K MT)
Table 155. Global Pharmaceutical Intermediates Sales Market Share Forecast by Regions (2021-2026)
Table 156. Global Pharmaceutical Intermediates Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 157. Global Pharmaceutical Intermediates Revenue Market Share Forecast by Regions (2021-2026)
Table 158. North America: Pharmaceutical Intermediates Sales Forecast by Country (2021-2026) (K MT)
Table 159. North America: Pharmaceutical Intermediates Revenue Forecast by Country (2021-2026) (US$ Million)
Table 160. Europe: Pharmaceutical Intermediates Sales Forecast by Country (2021-2026) (K MT)
Table 161. Europe: Pharmaceutical Intermediates Revenue Forecast by Country (2021-2026) (US$ Million)
Table 162. Asia Pacific: Pharmaceutical Intermediates Sales Forecast by Region (2021-2026) (K MT)
Table 163. Asia Pacific: Pharmaceutical Intermediates Revenue Forecast by Region (2021-2026) (US$ Million)
Table 164. Latin America: Pharmaceutical Intermediates Sales Forecast by Country (2021-2026) (K MT)
Table 165. Latin America: Pharmaceutical Intermediates Revenue Forecast by Country (2021-2026) (US$ Million)
Table 166. Middle East and Africa: Pharmaceutical Intermediates Sales Forecast by Country (2021-2026) (K MT)
Table 167. Middle East and Africa: Pharmaceutical Intermediates Revenue Forecast by Country (2021-2026) (US$ Million)
Table 168. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 169. Key Challenges
Table 170. Market Risks
Table 171. Main Points Interviewed from Key Pharmaceutical Intermediates Players
Table 172. Pharmaceutical Intermediates Customers List
Table 173. Pharmaceutical Intermediates Distributors List
Table 174. Research Programs/Design for This Report
Table 175. Key Data Information from Secondary Sources
Table 176. Key Data Information from Primary Sources
Table 1. Pharmaceutical Intermediates Market Segments
Table 2. Ranking of Global Top Pharmaceutical Intermediates Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Pharmaceutical Intermediates Market Size Growth Rate by Type 2020-2026 (K MT) & (US$ Million)
Table 4. Major Manufacturers of GMP
Table 5. Major Manufacturers of Non-GMP
Table 6. COVID-19 Impact Global Market: (Four Pharmaceutical Intermediates Market Size Forecast Scenarios)
Table 7. Opportunities and Trends for Pharmaceutical Intermediates Players in the COVID-19 Landscape
Table 8. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 9. Key Regions/Countries Measures against Covid-19 Impact
Table 10. Proposal for Pharmaceutical Intermediates Players to Combat Covid-19 Impact
Table 11. Global Pharmaceutical Intermediates Market Size Growth Rate by Application 2020-2026 (K MT)
Table 12. Global Pharmaceutical Intermediates Market Size by Region (K MT) & (US$ Million): 2020 VS 2026
Table 13. Global Pharmaceutical Intermediates Sales by Regions 2015-2020 (K MT)
Table 14. Global Pharmaceutical Intermediates Sales Market Share by Regions (2015-2020)
Table 15. Global Pharmaceutical Intermediates Revenue by Regions 2015-2020 (US$ Million)
Table 16. Global Pharmaceutical Intermediates Sales by Manufacturers (2015-2020) (K MT)
Table 17. Global Pharmaceutical Intermediates Sales Share by Manufacturers (2015-2020)
Table 18. Global Pharmaceutical Intermediates Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 19. Global Pharmaceutical Intermediates by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pharmaceutical Intermediates as of 2019)
Table 20. Pharmaceutical Intermediates Revenue by Manufacturers (2015-2020) (US$ Million)
Table 21. Pharmaceutical Intermediates Revenue Share by Manufacturers (2015-2020)
Table 22. Key Manufacturers Pharmaceutical Intermediates Price (2015-2020) (USD/MT)
Table 23. Pharmaceutical Intermediates Manufacturers Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Pharmaceutical Intermediates Product Type
Table 25. Date of International Manufacturers Enter into Pharmaceutical Intermediates Market
Table 26. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 27. Global Pharmaceutical Intermediates Sales by Type (2015-2020) (K MT)
Table 28. Global Pharmaceutical Intermediates Sales Share by Type (2015-2020)
Table 29. Global Pharmaceutical Intermediates Revenue by Type (2015-2020) (US$ Million)
Table 30. Global Pharmaceutical Intermediates Revenue Share by Type (2015-2020)
Table 31. Pharmaceutical Intermediates Average Selling Price (ASP) by Type 2015-2020 (USD/MT)
Table 32. Global Pharmaceutical Intermediates Sales by Application (2015-2020) (K MT)
Table 33. Global Pharmaceutical Intermediates Sales Share by Application (2015-2020)
Table 34. North America Pharmaceutical Intermediates Sales by Country (2015-2020) (K MT)
Table 35. North America Pharmaceutical Intermediates Sales Market Share by Country (2015-2020)
Table 36. North America Pharmaceutical Intermediates Revenue by Country (2015-2020) (US$ Million)
Table 37. North America Pharmaceutical Intermediates Revenue Market Share by Country (2015-2020)
Table 38. North America Pharmaceutical Intermediates Sales by Type (2015-2020) (K MT)
Table 39. North America Pharmaceutical Intermediates Sales Market Share by Type (2015-2020)
Table 40. North America Pharmaceutical Intermediates Sales by Application (2015-2020) (K MT)
Table 41. North America Pharmaceutical Intermediates Sales Market Share by Application (2015-2020)
Table 42. Europe Pharmaceutical Intermediates Sales by Country (2015-2020) (K MT)
Table 43. Europe Pharmaceutical Intermediates Sales Market Share by Country (2015-2020)
Table 44. Europe Pharmaceutical Intermediates Revenue by Country (2015-2020) (US$ Million)
Table 45. Europe Pharmaceutical Intermediates Revenue Market Share by Country (2015-2020)
Table 46. Europe Pharmaceutical Intermediates Sales by Type (2015-2020) (K MT)
Table 47. Europe Pharmaceutical Intermediates Sales Market Share by Type (2015-2020)
Table 48. Europe Pharmaceutical Intermediates Sales by Application (2015-2020) (K MT)
Table 49. Europe Pharmaceutical Intermediates Sales Market Share by Application (2015-2020)
Table 50. Asia Pacific Pharmaceutical Intermediates Sales by Region (2015-2020) (K MT)
Table 51. Asia Pacific Pharmaceutical Intermediates Sales Market Share by Region (2015-2020)
Table 52. Asia Pacific Pharmaceutical Intermediates Revenue by Region (2015-2020) (US$ Million)
Table 53. Asia Pacific Pharmaceutical Intermediates Revenue Market Share by Region (2015-2020)
Table 54. Asia Pacific Pharmaceutical Intermediates Sales by Type (2015-2020) (K MT)
Table 55. Asia Pacific Pharmaceutical Intermediates Sales Market Share by Type (2015-2020)
Table 56. Asia Pacific Pharmaceutical Intermediates Sales by Application (2015-2020) (K MT)
Table 57. Asia Pacific Pharmaceutical Intermediates Sales Market Share by Application (2015-2020)
Table 58. Latin America Pharmaceutical Intermediates Sales by Country (2015-2020) (K MT)
Table 59. Latin America Pharmaceutical Intermediates Sales Market Share by Country (2015-2020)
Table 60. Latin Americaa Pharmaceutical Intermediates Revenue by Country (2015-2020) (US$ Million)
Table 61. Latin America Pharmaceutical Intermediates Revenue Market Share by Country (2015-2020)
Table 62. Latin America Pharmaceutical Intermediates Sales by Type (2015-2020) (K MT)
Table 63. Latin America Pharmaceutical Intermediates Sales Market Share by Type (2015-2020)
Table 64. Latin America Pharmaceutical Intermediates Sales by Application (2015-2020) (K MT)
Table 65. Latin America Pharmaceutical Intermediates Sales Market Share by Application (2015-2020)
Table 66. Middle East and Africa Pharmaceutical Intermediates Sales by Country (2015-2020) (K MT)
Table 67. Middle East and Africa Pharmaceutical Intermediates Sales Market Share by Country (2015-2020)
Table 68. Middle East and Africa Pharmaceutical Intermediates Revenue by Country (2015-2020) (US$ Million)
Table 69. Middle East and Africa Pharmaceutical Intermediates Revenue Market Share by Country (2015-2020)
Table 70. Middle East and Africa Pharmaceutical Intermediates Sales by Type (2015-2020) (K MT)
Table 71. Middle East and Africa Pharmaceutical Intermediates Sales Market Share by Type (2015-2020)
Table 72. Middle East and Africa Pharmaceutical Intermediates Sales by Application (2015-2020) (K MT)
Table 73. Middle East and Africa Pharmaceutical Intermediates Sales Market Share by Application (2015-2020)
Table 74. Lonza Corporation Information
Table 75. Lonza Description and Major Businesses
Table 76. Lonza Pharmaceutical Intermediates Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 77. Lonza Product
Table 78. Lonza Recent Development
Table 79. Catalent Corporation Information
Table 80. Catalent Description and Major Businesses
Table 81. Catalent Pharmaceutical Intermediates Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 82. Catalent Product
Table 83. Catalent Recent Development
Table 84. Patheon Corporation Information
Table 85. Patheon Description and Major Businesses
Table 86. Patheon Pharmaceutical Intermediates Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 87. Patheon Product
Table 88. Patheon Recent Development
Table 89. Jubilant Corporation Information
Table 90. Jubilant Description and Major Businesses
Table 91. Jubilant Pharmaceutical Intermediates Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 92. Jubilant Product
Table 93. Jubilant Recent Development
Table 94. Granules Corporation Information
Table 95. Granules Description and Major Businesses
Table 96. Granules Pharmaceutical Intermediates Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 97. Granules Product
Table 98. Granules Recent Development
Table 99. Ganesh Corporation Information
Table 100. Ganesh Description and Major Businesses
Table 101. Ganesh Pharmaceutical Intermediates Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 102. Ganesh Product
Table 103. Ganesh Recent Development
Table 104. Chemcon Corporation Information
Table 105. Chemcon Description and Major Businesses
Table 106. Chemcon Pharmaceutical Intermediates Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 107. Chemcon Product
Table 108. Chemcon Recent Development
Table 109. BASF Corporation Information
Table 110. BASF Description and Major Businesses
Table 111. BASF Pharmaceutical Intermediates Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 112. BASF Product
Table 113. BASF Recent Development
Table 114. Porton Corporation Information
Table 115. Porton Description and Major Businesses
Table 116. Porton Pharmaceutical Intermediates Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 117. Porton Product
Table 118. Porton Recent Development
Table 119. Lianhetech Corporation Information
Table 120. Lianhetech Description and Major Businesses
Table 121. Lianhetech Pharmaceutical Intermediates Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 122. Lianhetech Product
Table 123. Lianhetech Recent Development
Table 124. ABA Chem Corporation Information
Table 125. ABA Chem Description and Major Businesses
Table 126. ABA Chem Pharmaceutical Intermediates Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 127. ABA Chem Product
Table 128. ABA Chem Recent Development
Table 129. Tianma Corporation Information
Table 130. Tianma Description and Major Businesses
Table 131. Tianma Pharmaceutical Intermediates Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 132. Tianma Product
Table 133. Tianma Recent Development
Table 134. Jiujiujiu Corporation Information
Table 135. Jiujiujiu Description and Major Businesses
Table 136. Jiujiujiu Pharmaceutical Intermediates Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 137. Jiujiujiu Product
Table 138. Jiujiujiu Recent Development
Table 139. Alpha Corporation Information
Table 140. Alpha Description and Major Businesses
Table 141. Alpha Pharmaceutical Intermediates Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 142. Alpha Product
Table 143. Alpha Recent Development
Table 144. Jiuzhou Corporation Information
Table 145. Jiuzhou Description and Major Businesses
Table 146. Jiuzhou Pharmaceutical Intermediates Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 147. Jiuzhou Product
Table 148. Jiuzhou Recent Development
Table 149. Yongtai Corporation Information
Table 150. Yongtai Description and Major Businesses
Table 151. Yongtai Pharmaceutical Intermediates Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 152. Yongtai Product
Table 153. Yongtai Recent Development
Table 154. Global Pharmaceutical Intermediates Sales Forecast by Regions (2021-2026) (K MT)
Table 155. Global Pharmaceutical Intermediates Sales Market Share Forecast by Regions (2021-2026)
Table 156. Global Pharmaceutical Intermediates Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 157. Global Pharmaceutical Intermediates Revenue Market Share Forecast by Regions (2021-2026)
Table 158. North America: Pharmaceutical Intermediates Sales Forecast by Country (2021-2026) (K MT)
Table 159. North America: Pharmaceutical Intermediates Revenue Forecast by Country (2021-2026) (US$ Million)
Table 160. Europe: Pharmaceutical Intermediates Sales Forecast by Country (2021-2026) (K MT)
Table 161. Europe: Pharmaceutical Intermediates Revenue Forecast by Country (2021-2026) (US$ Million)
Table 162. Asia Pacific: Pharmaceutical Intermediates Sales Forecast by Region (2021-2026) (K MT)
Table 163. Asia Pacific: Pharmaceutical Intermediates Revenue Forecast by Region (2021-2026) (US$ Million)
Table 164. Latin America: Pharmaceutical Intermediates Sales Forecast by Country (2021-2026) (K MT)
Table 165. Latin America: Pharmaceutical Intermediates Revenue Forecast by Country (2021-2026) (US$ Million)
Table 166. Middle East and Africa: Pharmaceutical Intermediates Sales Forecast by Country (2021-2026) (K MT)
Table 167. Middle East and Africa: Pharmaceutical Intermediates Revenue Forecast by Country (2021-2026) (US$ Million)
Table 168. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 169. Key Challenges
Table 170. Market Risks
Table 171. Main Points Interviewed from Key Pharmaceutical Intermediates Players
Table 172. Pharmaceutical Intermediates Customers List
Table 173. Pharmaceutical Intermediates Distributors List
Table 174. Research Programs/Design for This Report
Table 175. Key Data Information from Secondary Sources
Table 176. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Pharmaceutical Intermediates Product Picture
Figure 2. Global Pharmaceutical Intermediates Sales Market Share by Type in 2020 & 2026
Figure 3. GMP Product Picture
Figure 4. Non-GMP Product Picture
Figure 5. Global Pharmaceutical Intermediates Sales Market Share by Application in 2020 & 2026
Figure 6. Antibiotics
Figure 7. Antipyretic Analgesics
Figure 8. Vitamins
Figure 9. Others
Figure 10. Pharmaceutical Intermediates Report Years Considered
Figure 11. Global Pharmaceutical Intermediates Market Size 2015-2026 (US$ Million)
Figure 12. Global Pharmaceutical Intermediates Sales 2015-2026 (K MT)
Figure 13. Global Pharmaceutical Intermediates Market Size Market Share by Region: 2020 Versus 2026
Figure 14. Global Pharmaceutical Intermediates Sales Market Share by Region (2015-2020)
Figure 15. Global Pharmaceutical Intermediates Sales Market Share by Region in 2019
Figure 16. Global Pharmaceutical Intermediates Revenue Market Share by Region (2015-2020)
Figure 17. Global Pharmaceutical Intermediates Revenue Market Share by Region in 2019
Figure 18. Global Pharmaceutical Intermediates Sales Share by Manufacturer in 2019
Figure 19. The Top 10 and 5 Players Market Share by Pharmaceutical Intermediates Revenue in 2019
Figure 20. Pharmaceutical Intermediates Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 21. Global Pharmaceutical Intermediates Sales Market Share by Type (2015-2020)
Figure 22. Global Pharmaceutical Intermediates Sales Market Share by Type in 2019
Figure 23. Global Pharmaceutical Intermediates Revenue Market Share by Type (2015-2020)
Figure 24. Global Pharmaceutical Intermediates Revenue Market Share by Type in 2019
Figure 25. Global Pharmaceutical Intermediates Market Share by Price Range (2015-2020)
Figure 26. Global Pharmaceutical Intermediates Sales Market Share by Application (2015-2020)
Figure 27. Global Pharmaceutical Intermediates Sales Market Share by Application in 2019
Figure 28. Global Pharmaceutical Intermediates Revenue Market Share by Application (2015-2020)
Figure 29. Global Pharmaceutical Intermediates Revenue Market Share by Application in 2019
Figure 30. North America Pharmaceutical Intermediates Sales Growth Rate 2015-2020 (K MT)
Figure 31. North America Pharmaceutical Intermediates Revenue Growth Rate 2015-2020 (US$ Million)
Figure 32. North America Pharmaceutical Intermediates Sales Market Share by Country in 2019
Figure 33. North America Pharmaceutical Intermediates Revenue Market Share by Country in 2019
Figure 34. U.S. Pharmaceutical Intermediates Sales Growth Rate (2015-2020) (K MT)
Figure 35. U.S. Pharmaceutical Intermediates Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. Canada Pharmaceutical Intermediates Sales Growth Rate (2015-2020) (K MT)
Figure 37. Canada Pharmaceutical Intermediates Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. North America Pharmaceutical Intermediates Market Share by Type in 2019
Figure 39. North America Pharmaceutical Intermediates Market Share by Application in 2019
Figure 40. Europe Pharmaceutical Intermediates Sales Growth Rate 2015-2020 (K MT)
Figure 41. Europe Pharmaceutical Intermediates Revenue Growth Rate 2015-2020 (US$ Million)
Figure 42. Europe Pharmaceutical Intermediates Sales Market Share by Country in 2019
Figure 43. Europe Pharmaceutical Intermediates Revenue Market Share by Country in 2019
Figure 44. Germany Pharmaceutical Intermediates Sales Growth Rate (2015-2020) (K MT)
Figure 45. Germany Pharmaceutical Intermediates Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. France Pharmaceutical Intermediates Sales Growth Rate (2015-2020) (K MT)
Figure 47. France Pharmaceutical Intermediates Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. U.K. Pharmaceutical Intermediates Sales Growth Rate (2015-2020) (K MT)
Figure 49. U.K. Pharmaceutical Intermediates Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Italy Pharmaceutical Intermediates Sales Growth Rate (2015-2020) (K MT)
Figure 51. Italy Pharmaceutical Intermediates Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Russia Pharmaceutical Intermediates Sales Growth Rate (2015-2020) (K MT)
Figure 53. Russia Pharmaceutical Intermediates Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Europe Pharmaceutical Intermediates Market Share by Type in 2019
Figure 55. Europe Pharmaceutical Intermediates Market Share by Application in 2019
Figure 56. Asia Pacific Pharmaceutical Intermediates Sales Growth Rate 2015-2020 (K MT)
Figure 57. Asia Pacific Pharmaceutical Intermediates Revenue Growth Rate 2015-2020 (US$ Million)
Figure 58. Asia Pacific Pharmaceutical Intermediates Sales Market Share by Region in 2019
Figure 59. Asia Pacific Pharmaceutical Intermediates Revenue Market Share by Region in 2019
Figure 60. China Pharmaceutical Intermediates Sales Growth Rate (2015-2020) (K MT)
Figure 61. China Pharmaceutical Intermediates Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Japan Pharmaceutical Intermediates Sales Growth Rate (2015-2020) (K MT)
Figure 63. Japan Pharmaceutical Intermediates Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. South Korea Pharmaceutical Intermediates Sales Growth Rate (2015-2020) (K MT)
Figure 65. South Korea Pharmaceutical Intermediates Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. India Pharmaceutical Intermediates Sales Growth Rate (2015-2020) (K MT)
Figure 67. India Pharmaceutical Intermediates Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Australia Pharmaceutical Intermediates Sales Growth Rate (2015-2020) (K MT)
Figure 69. Australia Pharmaceutical Intermediates Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Taiwan Pharmaceutical Intermediates Sales Growth Rate (2015-2020) (K MT)
Figure 71. Taiwan Pharmaceutical Intermediates Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Indonesia Pharmaceutical Intermediates Sales Growth Rate (2015-2020) (K MT)
Figure 73. Indonesia Pharmaceutical Intermediates Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Thailand Pharmaceutical Intermediates Sales Growth Rate (2015-2020) (K MT)
Figure 75. Thailand Pharmaceutical Intermediates Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Malaysia Pharmaceutical Intermediates Sales Growth Rate (2015-2020) (K MT)
Figure 77. Malaysia Pharmaceutical Intermediates Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Philippines Pharmaceutical Intermediates Sales Growth Rate (2015-2020) (K MT)
Figure 79. Philippines Pharmaceutical Intermediates Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Vietnam Pharmaceutical Intermediates Sales Growth Rate (2015-2020) (K MT)
Figure 81. Vietnam Pharmaceutical Intermediates Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Asia Pacific Pharmaceutical Intermediates Market Share by Type in 2019
Figure 83. Asia Pacific Pharmaceutical Intermediates Market Share by Application in 2019
Figure 84. Latin America Pharmaceutical Intermediates Sales Growth Rate 2015-2020 (K MT)
Figure 85. Latin America Pharmaceutical Intermediates Revenue Growth Rate 2015-2020 (US$ Million)
Figure 86. Latin America Pharmaceutical Intermediates Sales Market Share by Country in 2019
Figure 87. Latin America Pharmaceutical Intermediates Revenue Market Share by Country in 2019
Figure 88. Mexico Pharmaceutical Intermediates Sales Growth Rate (2015-2020) (K MT)
Figure 89. Mexico Pharmaceutical Intermediates Revenue Growth Rate (2015-2020) (US$ Million)
Figure 90. Brazil Pharmaceutical Intermediates Sales Growth Rate (2015-2020) (K MT)
Figure 91. Brazil Pharmaceutical Intermediates Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Argentina Pharmaceutical Intermediates Sales Growth Rate (2015-2020) (K MT)
Figure 93. Argentina Pharmaceutical Intermediates Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Latin America Pharmaceutical Intermediates Market Share by Type in 2019
Figure 95. Latin America Pharmaceutical Intermediates Market Share by Application in 2019
Figure 96. Middle East and Africa Pharmaceutical Intermediates Sales Growth Rate 2015-2020 (K MT)
Figure 97. Middle East and Africa Pharmaceutical Intermediates Revenue Growth Rate 2015-2020 (US$ Million)
Figure 98. Middle East and Africa Pharmaceutical Intermediates Sales Market Share by Country in 2019
Figure 99. Middle East and Africa Pharmaceutical Intermediates Revenue Market Share by Country in 2019
Figure 100. Turkey Pharmaceutical Intermediates Sales Growth Rate (2015-2020) (K MT)
Figure 101. Turkey Pharmaceutical Intermediates Revenue Growth Rate (2015-2020) (US$ Million)
Figure 102. Saudi Arabia Pharmaceutical Intermediates Sales Growth Rate (2015-2020) (K MT)
Figure 103. Saudi Arabia Pharmaceutical Intermediates Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. UAE Pharmaceutical Intermediates Sales Growth Rate (2015-2020) (K MT)
Figure 105. UAE Pharmaceutical Intermediates Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. Middle East and Africa Pharmaceutical Intermediates Market Share by Type in 2019
Figure 107. Middle East and Africa Pharmaceutical Intermediates Market Share by Application in 2019
Figure 108. Lonza Total Revenue (US$ Million): 2019 Compared with 2018
Figure 109. Catalent Total Revenue (US$ Million): 2019 Compared with 2018
Figure 110. Patheon Total Revenue (US$ Million): 2019 Compared with 2018
Figure 111. Jubilant Total Revenue (US$ Million): 2019 Compared with 2018
Figure 112. Granules Total Revenue (US$ Million): 2019 Compared with 2018
Figure 113. Ganesh Total Revenue (US$ Million): 2019 Compared with 2018
Figure 114. Chemcon Total Revenue (US$ Million): 2019 Compared with 2018
Figure 115. BASF Total Revenue (US$ Million): 2019 Compared with 2018
Figure 116. Porton Total Revenue (US$ Million): 2019 Compared with 2018
Figure 117. Lianhetech Total Revenue (US$ Million): 2019 Compared with 2018
Figure 118. ABA Chem Total Revenue (US$ Million): 2019 Compared with 2018
Figure 119. Tianma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 120. Jiujiujiu Total Revenue (US$ Million): 2019 Compared with 2018
Figure 121. Alpha Total Revenue (US$ Million): 2019 Compared with 2018
Figure 122. Jiuzhou Total Revenue (US$ Million): 2019 Compared with 2018
Figure 123. Yongtai Total Revenue (US$ Million): 2019 Compared with 2018
Figure 124. North America Pharmaceutical Intermediates Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 125. North America Pharmaceutical Intermediates Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 126. Europe Pharmaceutical Intermediates Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 127. Europe Pharmaceutical Intermediates Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 128. Asia Pacific Pharmaceutical Intermediates Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 129. Asia Pacific Pharmaceutical Intermediates Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 130. Latin America Pharmaceutical Intermediates Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 131. Latin America Pharmaceutical Intermediates Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 132. Middle East and Africa Pharmaceutical Intermediates Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 133. Middle East and Africa Pharmaceutical Intermediates Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 134. Porter's Five Forces Analysis
Figure 135. Channels of Distribution
Figure 136. Distributors Profiles
Figure 137. Bottom-up and Top-down Approaches for This Report
Figure 138. Data Triangulation
Figure 139. Key Executives Interviewed
Figure 1. Pharmaceutical Intermediates Product Picture
Figure 2. Global Pharmaceutical Intermediates Sales Market Share by Type in 2020 & 2026
Figure 3. GMP Product Picture
Figure 4. Non-GMP Product Picture
Figure 5. Global Pharmaceutical Intermediates Sales Market Share by Application in 2020 & 2026
Figure 6. Antibiotics
Figure 7. Antipyretic Analgesics
Figure 8. Vitamins
Figure 9. Others
Figure 10. Pharmaceutical Intermediates Report Years Considered
Figure 11. Global Pharmaceutical Intermediates Market Size 2015-2026 (US$ Million)
Figure 12. Global Pharmaceutical Intermediates Sales 2015-2026 (K MT)
Figure 13. Global Pharmaceutical Intermediates Market Size Market Share by Region: 2020 Versus 2026
Figure 14. Global Pharmaceutical Intermediates Sales Market Share by Region (2015-2020)
Figure 15. Global Pharmaceutical Intermediates Sales Market Share by Region in 2019
Figure 16. Global Pharmaceutical Intermediates Revenue Market Share by Region (2015-2020)
Figure 17. Global Pharmaceutical Intermediates Revenue Market Share by Region in 2019
Figure 18. Global Pharmaceutical Intermediates Sales Share by Manufacturer in 2019
Figure 19. The Top 10 and 5 Players Market Share by Pharmaceutical Intermediates Revenue in 2019
Figure 20. Pharmaceutical Intermediates Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 21. Global Pharmaceutical Intermediates Sales Market Share by Type (2015-2020)
Figure 22. Global Pharmaceutical Intermediates Sales Market Share by Type in 2019
Figure 23. Global Pharmaceutical Intermediates Revenue Market Share by Type (2015-2020)
Figure 24. Global Pharmaceutical Intermediates Revenue Market Share by Type in 2019
Figure 25. Global Pharmaceutical Intermediates Market Share by Price Range (2015-2020)
Figure 26. Global Pharmaceutical Intermediates Sales Market Share by Application (2015-2020)
Figure 27. Global Pharmaceutical Intermediates Sales Market Share by Application in 2019
Figure 28. Global Pharmaceutical Intermediates Revenue Market Share by Application (2015-2020)
Figure 29. Global Pharmaceutical Intermediates Revenue Market Share by Application in 2019
Figure 30. North America Pharmaceutical Intermediates Sales Growth Rate 2015-2020 (K MT)
Figure 31. North America Pharmaceutical Intermediates Revenue Growth Rate 2015-2020 (US$ Million)
Figure 32. North America Pharmaceutical Intermediates Sales Market Share by Country in 2019
Figure 33. North America Pharmaceutical Intermediates Revenue Market Share by Country in 2019
Figure 34. U.S. Pharmaceutical Intermediates Sales Growth Rate (2015-2020) (K MT)
Figure 35. U.S. Pharmaceutical Intermediates Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. Canada Pharmaceutical Intermediates Sales Growth Rate (2015-2020) (K MT)
Figure 37. Canada Pharmaceutical Intermediates Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. North America Pharmaceutical Intermediates Market Share by Type in 2019
Figure 39. North America Pharmaceutical Intermediates Market Share by Application in 2019
Figure 40. Europe Pharmaceutical Intermediates Sales Growth Rate 2015-2020 (K MT)
Figure 41. Europe Pharmaceutical Intermediates Revenue Growth Rate 2015-2020 (US$ Million)
Figure 42. Europe Pharmaceutical Intermediates Sales Market Share by Country in 2019
Figure 43. Europe Pharmaceutical Intermediates Revenue Market Share by Country in 2019
Figure 44. Germany Pharmaceutical Intermediates Sales Growth Rate (2015-2020) (K MT)
Figure 45. Germany Pharmaceutical Intermediates Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. France Pharmaceutical Intermediates Sales Growth Rate (2015-2020) (K MT)
Figure 47. France Pharmaceutical Intermediates Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. U.K. Pharmaceutical Intermediates Sales Growth Rate (2015-2020) (K MT)
Figure 49. U.K. Pharmaceutical Intermediates Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Italy Pharmaceutical Intermediates Sales Growth Rate (2015-2020) (K MT)
Figure 51. Italy Pharmaceutical Intermediates Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Russia Pharmaceutical Intermediates Sales Growth Rate (2015-2020) (K MT)
Figure 53. Russia Pharmaceutical Intermediates Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Europe Pharmaceutical Intermediates Market Share by Type in 2019
Figure 55. Europe Pharmaceutical Intermediates Market Share by Application in 2019
Figure 56. Asia Pacific Pharmaceutical Intermediates Sales Growth Rate 2015-2020 (K MT)
Figure 57. Asia Pacific Pharmaceutical Intermediates Revenue Growth Rate 2015-2020 (US$ Million)
Figure 58. Asia Pacific Pharmaceutical Intermediates Sales Market Share by Region in 2019
Figure 59. Asia Pacific Pharmaceutical Intermediates Revenue Market Share by Region in 2019
Figure 60. China Pharmaceutical Intermediates Sales Growth Rate (2015-2020) (K MT)
Figure 61. China Pharmaceutical Intermediates Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Japan Pharmaceutical Intermediates Sales Growth Rate (2015-2020) (K MT)
Figure 63. Japan Pharmaceutical Intermediates Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. South Korea Pharmaceutical Intermediates Sales Growth Rate (2015-2020) (K MT)
Figure 65. South Korea Pharmaceutical Intermediates Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. India Pharmaceutical Intermediates Sales Growth Rate (2015-2020) (K MT)
Figure 67. India Pharmaceutical Intermediates Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Australia Pharmaceutical Intermediates Sales Growth Rate (2015-2020) (K MT)
Figure 69. Australia Pharmaceutical Intermediates Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Taiwan Pharmaceutical Intermediates Sales Growth Rate (2015-2020) (K MT)
Figure 71. Taiwan Pharmaceutical Intermediates Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Indonesia Pharmaceutical Intermediates Sales Growth Rate (2015-2020) (K MT)
Figure 73. Indonesia Pharmaceutical Intermediates Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Thailand Pharmaceutical Intermediates Sales Growth Rate (2015-2020) (K MT)
Figure 75. Thailand Pharmaceutical Intermediates Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Malaysia Pharmaceutical Intermediates Sales Growth Rate (2015-2020) (K MT)
Figure 77. Malaysia Pharmaceutical Intermediates Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Philippines Pharmaceutical Intermediates Sales Growth Rate (2015-2020) (K MT)
Figure 79. Philippines Pharmaceutical Intermediates Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Vietnam Pharmaceutical Intermediates Sales Growth Rate (2015-2020) (K MT)
Figure 81. Vietnam Pharmaceutical Intermediates Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Asia Pacific Pharmaceutical Intermediates Market Share by Type in 2019
Figure 83. Asia Pacific Pharmaceutical Intermediates Market Share by Application in 2019
Figure 84. Latin America Pharmaceutical Intermediates Sales Growth Rate 2015-2020 (K MT)
Figure 85. Latin America Pharmaceutical Intermediates Revenue Growth Rate 2015-2020 (US$ Million)
Figure 86. Latin America Pharmaceutical Intermediates Sales Market Share by Country in 2019
Figure 87. Latin America Pharmaceutical Intermediates Revenue Market Share by Country in 2019
Figure 88. Mexico Pharmaceutical Intermediates Sales Growth Rate (2015-2020) (K MT)
Figure 89. Mexico Pharmaceutical Intermediates Revenue Growth Rate (2015-2020) (US$ Million)
Figure 90. Brazil Pharmaceutical Intermediates Sales Growth Rate (2015-2020) (K MT)
Figure 91. Brazil Pharmaceutical Intermediates Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Argentina Pharmaceutical Intermediates Sales Growth Rate (2015-2020) (K MT)
Figure 93. Argentina Pharmaceutical Intermediates Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Latin America Pharmaceutical Intermediates Market Share by Type in 2019
Figure 95. Latin America Pharmaceutical Intermediates Market Share by Application in 2019
Figure 96. Middle East and Africa Pharmaceutical Intermediates Sales Growth Rate 2015-2020 (K MT)
Figure 97. Middle East and Africa Pharmaceutical Intermediates Revenue Growth Rate 2015-2020 (US$ Million)
Figure 98. Middle East and Africa Pharmaceutical Intermediates Sales Market Share by Country in 2019
Figure 99. Middle East and Africa Pharmaceutical Intermediates Revenue Market Share by Country in 2019
Figure 100. Turkey Pharmaceutical Intermediates Sales Growth Rate (2015-2020) (K MT)
Figure 101. Turkey Pharmaceutical Intermediates Revenue Growth Rate (2015-2020) (US$ Million)
Figure 102. Saudi Arabia Pharmaceutical Intermediates Sales Growth Rate (2015-2020) (K MT)
Figure 103. Saudi Arabia Pharmaceutical Intermediates Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. UAE Pharmaceutical Intermediates Sales Growth Rate (2015-2020) (K MT)
Figure 105. UAE Pharmaceutical Intermediates Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. Middle East and Africa Pharmaceutical Intermediates Market Share by Type in 2019
Figure 107. Middle East and Africa Pharmaceutical Intermediates Market Share by Application in 2019
Figure 108. Lonza Total Revenue (US$ Million): 2019 Compared with 2018
Figure 109. Catalent Total Revenue (US$ Million): 2019 Compared with 2018
Figure 110. Patheon Total Revenue (US$ Million): 2019 Compared with 2018
Figure 111. Jubilant Total Revenue (US$ Million): 2019 Compared with 2018
Figure 112. Granules Total Revenue (US$ Million): 2019 Compared with 2018
Figure 113. Ganesh Total Revenue (US$ Million): 2019 Compared with 2018
Figure 114. Chemcon Total Revenue (US$ Million): 2019 Compared with 2018
Figure 115. BASF Total Revenue (US$ Million): 2019 Compared with 2018
Figure 116. Porton Total Revenue (US$ Million): 2019 Compared with 2018
Figure 117. Lianhetech Total Revenue (US$ Million): 2019 Compared with 2018
Figure 118. ABA Chem Total Revenue (US$ Million): 2019 Compared with 2018
Figure 119. Tianma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 120. Jiujiujiu Total Revenue (US$ Million): 2019 Compared with 2018
Figure 121. Alpha Total Revenue (US$ Million): 2019 Compared with 2018
Figure 122. Jiuzhou Total Revenue (US$ Million): 2019 Compared with 2018
Figure 123. Yongtai Total Revenue (US$ Million): 2019 Compared with 2018
Figure 124. North America Pharmaceutical Intermediates Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 125. North America Pharmaceutical Intermediates Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 126. Europe Pharmaceutical Intermediates Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 127. Europe Pharmaceutical Intermediates Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 128. Asia Pacific Pharmaceutical Intermediates Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 129. Asia Pacific Pharmaceutical Intermediates Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 130. Latin America Pharmaceutical Intermediates Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 131. Latin America Pharmaceutical Intermediates Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 132. Middle East and Africa Pharmaceutical Intermediates Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 133. Middle East and Africa Pharmaceutical Intermediates Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 134. Porter's Five Forces Analysis
Figure 135. Channels of Distribution
Figure 136. Distributors Profiles
Figure 137. Bottom-up and Top-down Approaches for This Report
Figure 138. Data Triangulation
Figure 139. Key Executives Interviewed
